The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line

BACKGROUND: An in vitro model was developed to understand if celecoxib could synergize with Mitomycin C (MMC), commonly used for the prevention of non-muscle invasive bladder cancer recurrence, and eventually elucidate if the mechanism of interaction involves multi drug resistance (MDR) transporters...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pagliarulo, Vincenzo, Ancona, Patrizia, Niso, Mauro, Colabufo, Nicola Antonio, Contino, Marialessandra, Cormio, Luigi, Azzariti, Amalia, Pagliarulo, Arcangelo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669624/
https://ncbi.nlm.nih.gov/pubmed/23705854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-12-47
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados